Follow
Bin Chen
Title
Cited by
Cited by
Year
A survey of current trends in computational drug repositioning
J Li, S Zheng, B Chen, AJ Butte, SJ Swamidass, Z Lu
Briefings in bioinformatics 17 (1), 2-12, 2016
5172016
Chem2Bio2RDF: a semantic framework for linking and data mining chemogenomic and systems chemical biology data
B Chen, X Dong, D Jiao, H Wang, Q Zhu, Y Ding, D Wild
BMC bioinformatics 11 (1), 255, 2010
2682010
Gaining insight into off-target mediated effects of drug candidates with a comprehensive systems chemical biology analysis
J Scheiber, B Chen, M Milik, SCK Sukuru, A Bender, D Mikhailov, ...
Journal of chemical information and modeling 49 (2), 308-317, 2009
1932009
Assessing Drug Target Association using Semantic Linked Data
B Chen, Y Ding, DJ Wild
PLoS Computational Biology 8 (7), e1002574, 2012
1882012
Leveraging big data to transform target selection and drug discovery
B Chen, AJ Butte
Clinical Pharmacology & Therapeutics 99 (3), 285-297, 2016
1782016
Leveraging big data to transform target selection and drug discovery
B Chen, AJ Butte
Clinical Pharmacology & Therapeutics 99 (3), 285-297, 2016
1782016
Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets
B Chen, L Ma, H Paik, M Sirota, W Wei, MS Chua, S So, AJ Butte
Nature communications 8 (1), 16022, 2017
1752017
PubChem as a source of polypharmacology
B Chen, D Wild, R Guha
Journal of chemical information and modeling 49 (9), 2044-2055, 2009
1692009
The ChEMBL database as linked open data
EL Willighagen, A Waagmeester, O Spjuth, P Ansell, AJ Williams, ...
Journal of cheminformatics 5 (1), 1-12, 2013
1462013
Predicting drug target interactions using meta-path-based semantic network analysis
G Fu, Y Ding, A Seal, B Chen, Y Sun, E Bolton
BMC bioinformatics 17 (1), 1-10, 2016
1262016
Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types
K Yu, B Chen, D Aran, J Charalel, C Yau, DM Wolf, LJ Van ‘T Veer, ...
Nature communications 10 (1), 3574, 2019
1242019
Harnessing big ‘omics’ data and AI for drug discovery in hepatocellular carcinoma
B Chen, L Garmire, DF Calvisi, MS Chua, RK Kelley, X Chen
Nature Reviews Gastroenterology & Hepatology 17 (4), 238-251, 2020
1112020
Comparison of random forest and Pipeline Pilot Naive Bayes in prospective QSAR predictions.
B Chen, RP Sheridan, V Hornak, JH Voigt
Journal of Chemical Information and Modeling, 2012
1092012
A single H/ACA small nucleolar RNA mediates tumor suppression downstream of oncogenic RAS
M McMahon, A Contreras, M Holm, T Uechi, CM Forester, X Pang, ...
Elife 8, e48847, 2019
972019
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice
S Zhang, X Song, D Cao, Z Xu, B Fan, L Che, J Hu, B Chen, M Dong, ...
Journal of hepatology 67 (6), 1194-1203, 2017
952017
Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell …
B Chen, W Wei, L Ma, B Yang, RM Gill, MS Chua, AJ Butte, S So
Gastroenterology 152 (8), 2022-2036, 2017
912017
Evaluating cell lines as models for metastatic breast cancer through integrative analysis of genomic data
K Liu, PA Newbury, BS Glicksberg, WZD Zeng, S Paithankar, ...
Nature communications 10 (1), 2138, 2019
902019
Relating hepatocellular carcinoma tumor samples and cell lines using gene expression data in translational research
B Chen, M Sirota, H Fan-Minogue, D Hadley, AJ Butte
BMC medical genomics 8 (2), 1-10, 2015
892015
Relating genes to function: identifying enriched transcription factors using the ENCODE ChIP-Seq significance tool
RK Auerbach, B Chen, AJ Butte
Bioinformatics 29 (15), 1922-1924, 2013
822013
Characteristics of drug combination therapy in oncology by analyzing clinical trial data on ClinicalTrials. gov
M Wu, M Sirota, AJ Butte, BIN Chen
Pacific Symposium on Biocomputing Co-Chairs, 68-79, 2014
752014
The system can't perform the operation now. Try again later.
Articles 1–20